Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : THQ,Inc. (THQI) -- Ignore unavailable to you. Want to Upgrade?

To: AreWeThereYet who wrote (9310)	1/13/1999 2:24:00 PM
From: Sigmund	Read Replies (1) \| Respond to of 14266

OT Anyone heard from Aloha? His ADVH is up today big time. I think he sold out. When he made such a big fuss over ADVH I got interested and later bought in at under $2 so I am happy today about that anyway.

To: AreWeThereYet who wrote (9310)	1/13/1999 2:25:00 PM
From: Marc Newman	Read Replies (2) \| Respond to of 14266

Well, Navellier had it right this morning when he said to buy more of the companies that are having great earnings. Look at INTC, look at AAPL today. Meanwhile, look at AKLM in contrast. That was not a great report though I agree that it looks like management is lowballing expectations for the current quarter. I was half-expecting Navellier to mention THQ. It had a monster quarter, its on sale, and of course he owns 5-10% of the company. He had the perfect lead-in when he was asked about TOY. Anyway, hope people bought more. The drop is painful, yet it looks to me that THQI is still week enough that I'm going to get a fine price when I move some AAPL money into THQI tomorrow. Yes, you evil MMs, I am buying tomorrow so you can raise the price today if you wish. <<gg>> Marc Btw, CNBC said this morning that South America accounts for only 2.5% of S&P profits. It may have an outsized effect on financial firms, but certainly means less to tech firms than Asia did. Since THQI is on the NASDAQ, I predict less collateral damage, overall.